Your browser doesn't support javascript.
loading
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.
Brown, Timothy J; Gimotty, Phyllis A; Mamtani, Ronac; Karasic, Thomas B; Yang, Yu-Xiao.
Afiliación
  • Brown TJ; Division of Hematology/Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
  • Gimotty PA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Mamtani R; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.
  • Karasic TB; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Yang YX; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
JCO Clin Cancer Inform ; 8: e2300220, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39088775

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Bevacizumab / Neoplasias Hepáticas Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Clin Cancer Inform Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma Hepatocelular / Anticuerpos Monoclonales Humanizados / Bevacizumab / Neoplasias Hepáticas Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCO Clin Cancer Inform Año: 2024 Tipo del documento: Article